Human liver cancer cells (Hep G2-EGFP)

The Human liver cancer cells (Hep G2-EGFP) serve as a vital tool for cancer research and drug development enabling scientists to investigate the molecular mechanisms of liver cancer and the effectiveness of potential therapeutic agents With the capacity for dry ice preservation and efficient T25 live cell transportation these cells maintain their viability during shipping and storage allowing for seamless integration into research workflows Utilized in studies focused on gene expression and cellular behavior Hep G2-EGFP cells’ epithelioid adherent nature fosters reproducible experimentation in vitro while their engineered fluorescent properties facilitate real-time monitoring of cellular processes Furthermore owing to their human origin and negative virus status these cells provide a relevant model for evaluating the safety and efficacy of novel treatment strategies in the context of human biology